Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPC-16 in Dysmenorrhea
NCT02362711Phase 3Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Feb 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of ethinylestradiol + levonorgestrel in dysmenorrhea (3 arms), sponsored by Nobelpharma Co., Ltd. Primary endpoint: Total Dysmenorrhea Score at 52 weeks. Started Feb 2015; status: completed.
02
Drugs
ethinylestradiol + levonorgestrel
03
Conditions
dysmenorrhea
Beyond the preview
Go deeper on NCT02362711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02362711.